Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells.
Signaling via the type 1 insulin-like growth factor receptor (IGF1R) confers resistance to EGF receptor (EGFR) inhibitors. It is plausible that reciprocal EGFR compensation could mediate resistance to IGF1R inhibition, prompting us to investigate effects of IGF1R depletion on EGFR signaling in breas...
主要な著者: | Riedemann, J, Sohail, M, Macaulay, V |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2007
|
類似資料
-
The EGF receptor interacts with the type 1 IGF receptor and regulates its stability.
著者:: Riedemann, J, 等
出版事項: (2007) -
Radioresistant laryngeal cancers upregulate type 1 IGF receptor and exhibit increased cellular dependence on IGF and EGF signalling
著者:: Qureishi, A, 等
出版事項: (2019) -
IGF1R signalling and its inhibition.
著者:: Riedemann, J, 等
出版事項: (2006) -
Targeting the IGF receptor as treatment for cancer
著者:: Macaulay, V
出版事項: (2007) -
The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript.
著者:: Bohula, E, 等
出版事項: (2003)